nnc 112 has been researched along with ecopipam in 2 studies
| Studies (nnc 112) | Trials (nnc 112) | Recent Studies (post-2010) (nnc 112) | Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) |
|---|---|---|---|---|---|
| 32 | 3 | 7 | 147 | 18 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bøgesø, K; Liljefors, T; Pettersson, I | 1 |
| Wachtel, SR; White, FJ | 1 |
2 other study(ies) available for nnc 112 and ecopipam
| Article | Year |
|---|---|
Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Chemical Phenomena; Chemistry, Physical; Dopamine Agents; Dopamine Antagonists; Molecular Conformation; Molecular Structure; Receptors, Dopamine; Receptors, Dopamine D1; Structure-Activity Relationship; Thermodynamics | 1990 |
The effect of continuous and repeated administration of D1 dopamine receptor antagonist on midbrain dopamine neurons.
Topics: Animals; Benzazepines; Benzofurans; Dopamine; Dopamine Antagonists; Male; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1992 |